SCHOTT Pharma KGaA Balance Sheet Health
Financial Health criteria checks 5/6
SCHOTT Pharma KGaA has a total shareholder equity of €728.1M and total debt of €225.8M, which brings its debt-to-equity ratio to 31%. Its total assets and total liabilities are €1.4B and €630.9M respectively. SCHOTT Pharma KGaA's EBIT is €171.2M making its interest coverage ratio 41.6. It has cash and short-term investments of €19.0M.
Key information
31.0%
Debt to equity ratio
€225.84m
Debt
Interest coverage ratio | 41.6x |
Cash | €19.02m |
Equity | €728.12m |
Total liabilities | €630.92m |
Total assets | €1.36b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: 1SXP's short term assets (€571.8M) exceed its short term liabilities (€425.5M).
Long Term Liabilities: 1SXP's short term assets (€571.8M) exceed its long term liabilities (€205.4M).
Debt to Equity History and Analysis
Debt Level: 1SXP's net debt to equity ratio (28.4%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if 1SXP's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: 1SXP's debt is well covered by operating cash flow (77.5%).
Interest Coverage: 1SXP's interest payments on its debt are well covered by EBIT (41.6x coverage).